Cargando…

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma

Rho GTPase‐activating protein 42 was identified as an inhibitor of RhoA to maintain normal blood pressure homeostasis. However, the effect of ARHGAP42 in promoting cell malignancy in nasopharyngeal carcinoma is demonstrated in this study. Microarray and real‐time quantitative PCR were used for a mRN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qian, Lin, Xiao, Ding, Linxiaoxiao, Zeng, Yinduo, Pang, Danmei, Ouyang, Nengtai, Xiang, Yanqun, Yao, Herui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089169/ https://www.ncbi.nlm.nih.gov/pubmed/29936709 http://dx.doi.org/10.1002/cam4.1552

Ejemplares similares

Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network
por: Kiso, Marina, et al.
Publicado: (2018)

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
por: Zhang, Wei, et al.
Publicado: (2019)

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
por: Liu, Gao, et al.
Publicado: (2021)

Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway
por: Huang, Yun, et al.
Publicado: (2020)

MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT pathway
por: Zhang, Liang, et al.
Publicado: (2020)

Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway
por: Zhu, Biqiang, et al.
Publicado: (2019)

Knockdown of ARHGAP30 inhibits ovarian cancer cell proliferation, migration, and invasiveness by suppressing the PI3K/AKT/mTOR signaling pathway
por: Chu, Xiaoyan, et al.
Publicado: (2023)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia
por: Kreider-Letterman, Gabriel, et al.
Publicado: (2022)

Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway
por: Wang, Yingying, et al.
Publicado: (2021)

Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway
por: Zhang, Gui-Hua, et al.
Publicado: (2020)

Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation
por: Zhu, Haoran, et al.
Publicado: (2022)

Development and validation of a nomogram in survival prediction among advanced breast cancer patients
por: Zhao, Jianli, et al.
Publicado: (2020)

Effects of miR‐145‐5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways
por: Liu, Sha, et al.
Publicado: (2017)

MicroRNA‐4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non‐small cell lung cancer
por: Ling, Chunhua, et al.
Publicado: (2019)

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways
por: Yang, Liang, et al.
Publicado: (2020)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
por: Yang, Ying, et al.
Publicado: (2021)

Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells
por: Hunter, Jill E., et al.
Publicado: (2022)

PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer
por: Barber, Alison G, et al.
Publicado: (2015)

The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
por: Liu, Jin, et al.
Publicado: (2020)

LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613
por: Yao, Qiying, et al.
Publicado: (2021)

LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells by inactivating PI3K/Akt pathway
por: Gao, Ting, et al.
Publicado: (2020)

Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
por: Cai, Fangzhen, et al.
Publicado: (2020)

PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex
por: Javadi, Arman, et al.
Publicado: (2017)

Non-canonical Notch Signaling Regulates Actin Remodeling in Cell Migration by Activating PI3K/AKT/Cdc42 Pathway
por: Liu, Lei, et al.
Publicado: (2019)

Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway
por: Zhou, Danyang, et al.
Publicado: (2018)

Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K/AKT pathway
por: Ying, Jun, et al.
Publicado: (2022)

Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system
por: Gui, Xiujuan, et al.
Publicado: (2023)

Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment
por: Liu, Dazhi, et al.
Publicado: (2022)

14‐3‐3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling
por: Li, Junjun, et al.
Publicado: (2019)

Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down‐regulating PI3K/AKT pathway
por: Wang, Chenjie, et al.
Publicado: (2019)

MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1
por: Hu, Weiqun, et al.
Publicado: (2020)

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer
por: Zhang, Cheng, et al.
Publicado: (2019)

FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway
por: Wang, Baolin, et al.
Publicado: (2021)

ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway
por: Lin, Lan-Lan, et al.
Publicado: (2021)

Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma
por: Zhu, Ziyu, et al.
Publicado: (2018)

Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences
por: Cacheux, Wulfran, et al.
Publicado: (2018)

Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
por: Emran, Abdullah Al, et al.
Publicado: (2019)

Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway
por: Zhou, Wenjing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ddfplpjfhmn3l9nb8qeaf4mjmf